Alirocumab treatment and neurocognitive function according to the CANTAB scale in patients at increased cardiovascular risk: a prospective, randomized, placebo-controlled study

Janik, Matthew J., Urbach, Dorothea V., van Nieuwenhuizen, Elane · Atherosclerosis · 2021